Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer

NCT06406608 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

20

Enrollment

OTHER_GOV

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

OTHER: Chemotherapy and targeted-therapy guided by organoid drug sensitivity test

Sponsor

Henan Cancer Hospital

Collaborators

[object Object]